The FDA has issued a complete response letter regarding the New Drug Application (NDA) for investigational compound dapa…
Articles by ASweetLife Team
Paula Deen Announces Type 2 Diabetes Diagnosis and Partners Up with Novo Nordisk
After days of rumors regarding Paula Deen's diabetes diagnosis, the woman dubbed the Queen of Southern Cuisine has annou…
KalVista and JDRF to Join Forces on New Treatments for Diabetic Eye Disease
KalVista Pharmaceuticals (“KalVista”) and JDRF have formed a research partnership focused on a novel approach being deve…
Medtronic Launches mySentry the First-Of-Its-Kind Remote Glucose Monitor
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a par…
Medtronic Launches mySentry the First-Of-Its-Kind Remote Glucose Monitor
Medtronic announced the U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a par…
Osiris Provides Update on Stem Cell Trial for Type 1 Diabetes
One year after Osiris Therapeutics in partnership with JDRF started the Phase 2 trial evaluating Prochymal, a formulatio…
Spring To Launch Special Infusion Sets for Children with Diabetes
Since its recent commercial launch, the Spring Universal Infusion Set has been particularly well received by parents of …
Study Reveals New Understanding of Type 1 Diabetes Development
Researchers from the John Curtin School of Medical Research in Canberra, Australia have discovered that the insulin-prod…
Novartis Terminates Study in Type 2 Diabetes Patients
Novartis has decided to terminate the ALTITUDE study evaluating the potential benefits of Rasilez/Tekturna (aliskiren) i…
JDRF to Support Cell Therapy Research for Type 1 Diabetes
JDRF announced it will support a pioneering diabetes research program that is developing a first-of-its-kind cell therap…
